Early recurrence factors in patients with stage III non‐small cell lung cancer treated with concurrent chemoradiotherapy
Abstract Background The clinical characteristics and risk factors for cancer recurrence have not been well evaluated regarding early recurrence in patients with unresectable locally advanced non‐small cell lung cancer (LA‐NSCLC) who receive concurrent chemoradiotherapy (CRT). The aim of this study w...
Main Authors: | Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14704 |
Similar Items
-
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series
by: Yutaka Takahara, et al.
Published: (2023-01-01) -
Influencing factors of efficacy and long‐term use of amrubicin in patients with small cell lung cancer
by: Yutaka Takahara, et al.
Published: (2023-05-01) -
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non‐small cell lung cancer
by: Yutaka Takahara, et al.
Published: (2022-02-01) -
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows
by: Yutaka Takahara, et al.
Published: (2021-10-01) -
Disease control in patients with non‐small cell lung cancer using pemetrexed: Investigating the best treatment strategy
by: Yutaka Takahara, et al.
Published: (2024-04-01)